Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Physical characterization of the aerosol of an electronic cigarette: impact of refill liquids.

Zervas E, Litsiou E, Konstantopoulos K, Poulopoulos S, Katsaounou P.

Inhal Toxicol. 2018 Sep 26:1-6. doi: 10.1080/08958378.2018.1500662. [Epub ahead of print]

PMID:
30257112
2.

An algorithmic approach for the treatment of severe uncontrolled asthma.

Zervas E, Samitas K, Papaioannou AI, Bakakos P, Loukides S, Gaga M.

ERJ Open Res. 2018 Mar 6;4(1). pii: 00125-2017. doi: 10.1183/23120541.00125-2017. eCollection 2018 Jan. Review.

3.

Inhaler adherence in severe asthma: is there an electronic solution?

Gaga M, Samitas K, Zervas E.

Eur Respir J. 2018 Jan 4;51(1). pii: 1702219. doi: 10.1183/13993003.02219-2017. Print 2018 Jan. No abstract available.

PMID:
29301915
4.

Authors' response.

Zervas ED, Galang-Boquiren MTS, Obrez A, Costa Viana MG, Kusnoto B, Oppermann N, Sanchez F, Romero EG.

Am J Orthod Dentofacial Orthop. 2017 Jul;152(1):10-11. doi: 10.1016/j.ajodo.2017.04.006. No abstract available.

PMID:
28651754
5.

Novel Biomarkers in Severe Asthma.

Zervas E, Samitas K, Gaga M.

Arch Bronconeumol. 2017 Apr;53(4):175-176. doi: 10.1016/j.arbres.2016.11.017. Epub 2017 Mar 7. English, Spanish. No abstract available.

6.

Targeting immunoglobulin E in non-atopic asthma: crossing the red line?

Gaga M, Zervas E, Humbert M.

Eur Respir J. 2016 Dec;48(6):1538-1540. doi: 10.1183/13993003.01797-2016. No abstract available.

7.

Change in the vertical dimension of Class II Division 1 patients after use of cervical or high-pull headgear.

Zervas ED, Galang-Boquiren MT, Obrez A, Costa Viana MG, Oppermann N, Sanchez F, Romero EG, Kusnoto B.

Am J Orthod Dentofacial Orthop. 2016 Nov;150(5):771-781. doi: 10.1016/j.ajodo.2016.04.024.

PMID:
27871703
8.

Presence of music while eating: Effects on energy intake, eating rate and appetite sensations.

Mamalaki E, Zachari K, Karfopoulou E, Zervas E, Yannakoulia M.

Physiol Behav. 2017 Jan 1;168:31-33. doi: 10.1016/j.physbeh.2016.10.019. Epub 2016 Oct 24.

PMID:
27789251
9.

T2-low asthma: current approach to diagnosis and therapy.

Samitas K, Zervas E, Gaga M.

Curr Opin Pulm Med. 2017 Jan;23(1):48-55. Review.

PMID:
27798418
10.

Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.

Zervas E, Samitas K, Gaga M.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 5;11:1845-55. doi: 10.2147/COPD.S113870. eCollection 2016.

11.

Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes.

Samitas K, Poulos N, Semitekolou M, Morianos I, Tousa S, Economidou E, Robinson DS, Kariyawasam HH, Zervas E, Corrigan CJ, Ying S, Xanthou G, Gaga M.

Eur Respir J. 2016 Mar;47(3):769-82. doi: 10.1183/13993003.00437-2015. Epub 2016 Feb 11.

12.

Clinical asthma phenotypes in the real world: opportunities and challenges.

Bostantzoglou C, Delimpoura V, Samitas K, Zervas E, Kanniess F, Gaga M.

Breathe (Sheff). 2015 Sep;11(3):186-93. doi: 10.1183/20734735.008115. Review.

13.

Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives.

Samitas K, Delimpoura V, Zervas E, Gaga M.

Eur Respir Rev. 2015 Dec;24(138):594-601. doi: 10.1183/16000617.00001715. Review.

14.

Control of asthma in real life: still a valuable goal?

Papaioannou AI, Kostikas K, Zervas E, Kolilekas L, Papiris S, Gaga M.

Eur Respir Rev. 2015 Jun;24(136):361-9. doi: 10.1183/16000617.00001615. Review.

15.

Mediastinal widening and miliary chest radiograph pattern in a middle aged man: could it be sarcoidosis?

Bostantzoglou C, Samitas K, Gkogkou C, Zervas E, Gaga M.

BMJ Case Rep. 2014 Jul 17;2014. pii: bcr2014204884. doi: 10.1136/bcr-2014-204884.

16.

Airway and systemic eosinophilia in asthma: does site matter?

Kostikas K, Zervas E, Gaga M.

Eur Respir J. 2014 Jul;44(1):14-6. doi: 10.1183/09031936.00034514. No abstract available.

17.

Circulating conventional and plasmacytoid dendritic cell subsets display distinct kinetics during in vivo repeated allergen skin challenges in atopic subjects.

Vittorakis S, Samitas K, Tousa S, Zervas E, Aggelakopoulou M, Semitekolou M, Panoutsakopoulou V, Xanthou G, Gaga M.

Biomed Res Int. 2014;2014:231036. doi: 10.1155/2014/231036. Epub 2014 Apr 28.

18.

Breathing for two: pregnancy, asthma and respiratory failure.

Gaga M, Zervas E.

Eur Respir Rev. 2014 Mar 1;23(131):5-7. doi: 10.1183/09059180.00000914. No abstract available.

19.

Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy.

Delimpoura V, Samitas K, Vamvakaris I, Zervas E, Gaga M.

BMJ Case Rep. 2013 Oct 10;2013. pii: bcr2013200624. doi: 10.1136/bcr-2013-200624.

20.

Granule cytotoxic activity and oxidative DNA damage in smoking and nonsmoking patients with asthma.

Proklou A, Soulitzis N, Neofytou E, Rovina N, Zervas E, Gaga M, Siafakas NM, Tzortzaki EG.

Chest. 2013 Oct;144(4):1230-1237. doi: 10.1378/chest.13-0367.

PMID:
23702636
21.

Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics.

Samitas K, Zervas E, Xanthou G, Panoutsakopoulou V, Gaga M.

Cytokine. 2013 Mar;61(3):713-5. doi: 10.1016/j.cyto.2012.12.028. Epub 2013 Feb 4. No abstract available.

PMID:
23384656
22.

Multiple tuberculous abscesses and mediastinal lymphadenitis with no pulmonary involvement in an immunocompetent patient.

Samitas K, Marinakis E, Birbilis C, Thanos L, Zervas E, Gaga M, Diamanti-Kandarakis E.

Indian J Tuberc. 2012 Oct;59(4):235-9.

PMID:
23342545
23.

Inhaled corticosteroids in COPD: pros and cons.

Zervas E, Samitas K, Gaga M, Beghe B, Fabbri LM.

Curr Drug Targets. 2013 Feb;14(2):192-224. Review.

PMID:
23256718
24.

Severe asthma in adults: an orphan disease?

Gaga M, Zervas E, Samitas K, Bel EH.

Clin Chest Med. 2012 Sep;33(3):571-83. doi: 10.1016/j.ccm.2012.06.008. Epub 2012 Aug 2. Review.

PMID:
22929103
25.

Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial.

Nair P, Gaga M, Zervas E, Alagha K, Hargreave FE, O'Byrne PM, Stryszak P, Gann L, Sadeh J, Chanez P; Study Investigators.

Clin Exp Allergy. 2012 Jul;42(7):1097-103. doi: 10.1111/j.1365-2222.2012.04014.x.

PMID:
22702508
26.

Letter to the editor--osteopontin levels in human asthma.

Samitas K, Zervas E, Panoutsakopoulou V, Gaga M.

J Int Med Res. 2011;39(6):2441-2. No abstract available.

PMID:
22289565
27.

Osteopontin expression and relation to disease severity in human asthma.

Samitas K, Zervas E, Vittorakis S, Semitekolou M, Alissafi T, Bossios A, Gogos H, Economidou E, Lötvall J, Xanthou G, Panoutsakopoulou V, Gaga M.

Eur Respir J. 2011 Feb;37(2):331-41. doi: 10.1183/09031936.00017810. Epub 2010 Jun 18.

28.

Update on severe asthma: what we know and what we need.

Gaga M, Zervas E, Chanez P.

Eur Respir Rev. 2009 Jun;18(112):58-65. doi: 10.1183/09059180.00001009. Review. No abstract available.

29.

Control of asthma.

Zervas E, Oikonomidou E, Kainis E, Kokkala M, Petroheilou K, Gaga M.

Ther Adv Respir Dis. 2008 Jun;2(3):141-8. doi: 10.1177/1753465808091664. Review.

PMID:
19124366
30.

Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity.

Samitas K, Chorianopoulos D, Vittorakis S, Zervas E, Economidou E, Papatheodorou G, Loukides S, Gaga M.

Respir Med. 2009 May;103(5):750-6. doi: 10.1016/j.rmed.2008.11.009. Epub 2008 Dec 24.

31.

Eosinophilic infiltration in the nasal mucosa of rhinitis patients: is it affected by the presence of asthma or the allergic status of the patients?

Lambrou P, Zervas E, Oikonomidou E, Papageorgiou N, Alchanatis M, Gaga M.

Ann Allergy Asthma Immunol. 2007 Jun;98(6):567-72.

PMID:
17601271
32.

Evaluation and management of severe asthma.

Gaga M, Zervas E, Grivas S, Castro M, Chanez P.

Curr Med Chem. 2007;14(9):1049-59. Review.

PMID:
17439402
33.

Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease.

Zervou MI, Tzortzaki EG, Makris D, Gaga M, Zervas E, Economidou E, Tsoumakidou M, Tzanakis N, Milic-Emili J, Siafakas NM.

Eur Respir J. 2006 Sep;28(3):472-8. Epub 2006 May 17.

34.

Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire.

Gaga M, Papageorgiou N, Yiourgioti G, Karydi P, Liapikou A, Bitsakou H, Zervas E, Koulouris NG, Holgate ST; ENFUMOSA Study Group.

Clin Exp Allergy. 2005 Jul;35(7):954-9.

PMID:
16008684
35.

Control of asthma under specialist care: is it achieved?

Gaga M, Papageorgiou N, Zervas E, Gioulekas D, Konstantopoulos S.

Chest. 2005 Jul;128(1):78-84.

PMID:
16002919
36.

Emissions of regulated pollutants from a spark ignition engine. Influence of fuel and air/fuel equivalence ratio.

Zervas E, Montagne X, Lahaye J.

Environ Sci Technol. 2003 Jul 15;37(14):3232-8.

PMID:
12901674
37.

The usefulness of inflammatory markers in monitoring treatment responses in asthma.

Gaga M, Zervas E, Loukides S.

Clin Exp Allergy. 2003 Jul;33(7):855-8. No abstract available.

PMID:
12859438
38.

Reduced intracellular Mg concentrations in patients with acute asthma.

Zervas E, Papatheodorou G, Psathakis K, Panagou P, Georgatou N, Loukides S.

Chest. 2003 Jan;123(1):113-8.

PMID:
12527611
39.

Emission of alcohols and carbonyl compounds from a spark ignition engine. Influence of fuel and air/fuel equivalence ratio.

Zervas E, Montagne X, Lahaye J.

Environ Sci Technol. 2002 Jun 1;36(11):2414-21.

PMID:
12075798
40.

C1-C5 organic acid emissions from an SI engine: influence of fuel and air/fuel equivalence ratio.

Zervas E, Montagne X, Lahaye J.

Environ Sci Technol. 2001 Jul 1;35(13):2746-51.

PMID:
11452603
41.

Magnesium levels in plasma and erythrocytes before and after histamine challenge.

Zervas E, Loukides S, Papatheodorou G, Psathakis K, Tsindiris K, Panagou P, Kalogeropoulos N.

Eur Respir J. 2000 Oct;16(4):621-5.

42.

The Influence of Gasoline Formulation on Specific Pollutant Emissions.

Zervas E, Montagne X, Lahaye J.

J Air Waste Manag Assoc. 1999 Nov;49(11):1304-1314. doi: 10.1080/10473289.1999.10463969.

PMID:
28072374
43.

Using recurrent neural networks for adaptive communication channel equalization.

Kechriotis G, Zervas E, Manolakos ES.

IEEE Trans Neural Netw. 1994;5(2):267-78.

PMID:
18267796

Supplemental Content

Loading ...
Support Center